These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2523787)

  • 1. The effects of metformin on adipocyte insulin action and metabolic control in obese subjects with type 2 diabetes.
    Pedersen O; Nielsen O; Bak J; Richelsen B; Beck-Nielsen H; Sørensen N
    Diabet Med; 1989 Apr; 6(3):249-56. PubMed ID: 2523787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes.
    Hother-Nielsen O; Schmitz O; Andersen PH; Beck-Nielsen H; Pedersen O
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):257-65. PubMed ID: 2648723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
    Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of metformin: insulin receptor and postreceptor effects in vitro and in vivo.
    Fantus IG; Brosseau R
    J Clin Endocrinol Metab; 1986 Oct; 63(4):898-905. PubMed ID: 3745404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
    Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM
    Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sulfonylureas on adipocyte and skeletal muscle insulin action in patients with non-insulin-dependent diabetes mellitus.
    Pedersen O; Hother-Nielsen O; Bak J; Hjollund E; Beck-Nielsen H
    Am J Med; 1991 Jun; 90(6A):22S-28S. PubMed ID: 1908182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mixed meal potentiates the insulin sensitivity of glucose transport and metabolism in adipocytes from patients with type 2 diabetes mellitus.
    Lange A; Bak J; Andersen PH; Richelsen B; Pedersen O
    Diabet Med; 1988 Nov; 5(8):761-5. PubMed ID: 2975568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects.
    Ciaraldi TP; Kong AP; Chu NV; Kim DD; Baxi S; Loviscach M; Plodkowski R; Reitz R; Caulfield M; Mudaliar S; Henry RR
    Diabetes; 2002 Jan; 51(1):30-6. PubMed ID: 11756319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of obesity, hyperinsulinemia, and glucose intolerance on insulin action in adipose tissue of sixty-year-old men.
    Bolinder J; Lithell H; Skarfors E; Arner P
    Diabetes; 1986 Mar; 35(3):282-90. PubMed ID: 3512339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients.
    Johnson AB; Webster JM; Sum CF; Heseltine L; Argyraki M; Cooper BG; Taylor R
    Metabolism; 1993 Sep; 42(9):1217-22. PubMed ID: 8412779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin receptor binding and metabolic effects of insulin in human subcutaneous adipose tissue in untreated non-insulin dependent diabetes mellitus.
    Arner P; Engfeldt P; Skarfors E; Lithell H; Bolinder J
    Ups J Med Sci; 1987; 92(1):47-58. PubMed ID: 3296383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
    Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM.
    Jeppesen J; Zhou MY; Chen YD; Reaven GM
    Diabetes Care; 1994 Oct; 17(10):1093-9. PubMed ID: 7821127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with non-insulin-dependent (type 2) diabetes mellitus.
    Nagi DK; Ali VM; Yudkin JS
    Diabet Med; 1996 Aug; 13(8):753-7. PubMed ID: 8862952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects.
    Virtanen KA; Hällsten K; Parkkola R; Janatuinen T; Lönnqvist F; Viljanen T; Rönnemaa T; Knuuti J; Huupponen R; Lönnroth P; Nuutila P
    Diabetes; 2003 Feb; 52(2):283-90. PubMed ID: 12540598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes.
    Tiikkainen M; Häkkinen AM; Korsheninnikova E; Nyman T; Mäkimattila S; Yki-Järvinen H
    Diabetes; 2004 Aug; 53(8):2169-76. PubMed ID: 15277403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocyte insulin binding and action in moderately obese NIDDM patients after dietary control of plasma glucose: reversal of postbinding abnormalities.
    Hjøllund E; Pedersen O; Sørensen NS
    Diabetes Care; 1987; 10(3):306-12. PubMed ID: 3595396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.